Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 5/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.62 |
| ▸ | WDR5 | P61964 | 4/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.62 |
| ▸ | LMNA | P02545 | 4/20 | 0.62 |
| ▸ | ENGASE | Q8NFI3 | 3/20 | 0.62 |
| ▸ | MAPT | P10636 | 3/20 | 0.62 |
| ▸ | DDAH1 | O94760 | 2/20 | 0.62 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.62 |
| ▸ | HPGD | P15428 | 2/20 | 0.62 |
| ▸ | TBXA2R | P21731 | 2/20 | 0.62 |
| ▸ | NPY1R | P25929 | 2/20 | 0.62 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.62 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.62 |
| ▸ | HTR3A | P46098 | 2/20 | 0.62 |
| ▸ | FASN | P49327 | 2/20 | 0.62 |
| ▸ | SARM1 | Q6SZW1 | 2/20 | 0.62 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.62 |
| ▸ | HTR1A | P08908 | 1/20 | 0.62 |
| ▸ | IDE | P14735 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1307379 | 0.99 | KMT2A (0.63) | CYP2C9KMT2AWDR5ALDH1A1LMNA | |
| SCHEMBL30905609 | 0.99 | KMT2A (0.63) | CYP2C9KMT2AWDR5ALDH1A1LMNA | |
| SCHEMBL6600434 | 0.98 | KMT2A (0.62) | CYP2C9KMT2AWDR5ALDH1A1LMNA | |
| SCHEMBL10121508 | 0.88 | KMT2A (0.62) | CYP2C9KMT2AWDR5ALDH1A1LMNA | |
| SCHEMBL23988420 | 0.87 | CYP2C9 (0.51) | CYP2C9KMT2AWDR5ALDH1A1LMNA | |
| SCHEMBL2851052 | 0.85 | KMT2A (0.59) | CYP2C9KMT2AWDR5ALDH1A1LMNA | |
| SCHEMBL23988519 | 0.85 | CYP2C9 (0.53) | CYP2C9KMT2AWDR5ALDH1A1LMNA | |
| SCHEMBL5414007 | 0.84 | KMT2A (0.60) | CYP2C9KMT2AWDR5ALDH1A1LMNA | |
| SCHEMBL23988509 | 0.84 | CYP2C9 (0.47) | CYP2C9KMT2AWDR5ALDH1A1LMNA | |
| SCHEMBL2851048 | 0.83 | KMT2A (0.59) | CYP2C9KMT2AWDR5ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112521370-B | Radioisotope carbon-14labeled D-rabeprazole sodium and synthetic method thereof | 浙江爱索拓科技有限公司 | 2021-11-02 | — | — | CN | disclosed |
| CN-112521370-A | Radioisotope carbon-14labeled D-rabeprazole sodium and synthetic method thereof | 上海启甄环境科技有限公司 | 2021-03-19 | — | — | CN | disclosed |
| US-20040180935-A1 | Crystalline form Z of rabeprazole sodium and process for preparation thereof | DR. REDDY'S LABORATORIES LIMITED DR. REDDY'S LABORATORIES INC. | 2004-09-16 | — | — | US | disclosed |
| EP-1452533-A1 | Crystalline form Z of rabeprazole sodium and process for preparation thereof | Dr. Reddy's Laboratories Ltd. (IN) | 2004-09-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040180935-A1 | Crystalline form Z of rabeprazole sodium and process for preparation thereof | CTSZ, RAB35, RAB14 | CYP2C9 61/4885KMT2A 3535/4885WDR5 3186/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.